Rigel Pharmaceuticals reported $129K in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Agenus AGEN:US $ 667K 438K
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Amgen AMGN:US $ 1637M 147M
Anika Therapeutics ANIK:US $ 17.33M 4.01M
AstraZeneca AZN:LN 2193M 273M
Astrazeneca AZN:US 2.19B 273M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Bristol Myers Squibb BMY:US $ 2451M 52M
Daiichi Sankyo 4568:JP Y 85152M 3275M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Flexion Therapeutics FLXN:US $ 4.98M 1.11M
Halozyme Therapeutics HALO:US $ 23.02M 4.8M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Intrexon XON:US $ 15.03M 2.06M
IONIS PHARMACEUT IONS:US $ 2.96M 0.38M
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
Ligand Pharmaceuticals LGND:US $ 30.59M 22.44M
MacroGenics MGNX:US 22K 5K
Neurocrine Biosciences NBIX:US $ 3.1M 0.2M
Pfizer PFE:US $ 6992M 2820M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Rigel Pharmaceuticals RIGL:US $ 0.13M 0.19M
Ultragenyx Pharmaceutical RARE:US $ 3.14M 2.05M
Veracyte VCYT:US $ 17.47M 5.07M